HEADER TRANSFERASE/TRANSFERASE INHIBITOR 19-AUG-20 7JU5 TITLE STRUCTURE OF RET PROTEIN TYROSINE KINASE IN COMPLEX WITH PRALSETINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CADHERIN FAMILY MEMBER 12,PROTO-ONCOGENE C-RET; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RET, CDHF12, CDHR16, PTC, RET51; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 1 BOLD-2017; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 2449148; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPAK6 KEYWDS ONCOGENE, RET, TYROSINE KINASE, ATP-BINDING, THYROID CANCER, NON KEYWDS 2 SMALL CELL LUNG CANCER, PRALSETINIB, TRANSFERASE-TRANSFERASE KEYWDS 3 INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.S.TERZYAN,T.SHEN,J.WU,B.H.M.MOOERS REVDAT 4 18-OCT-23 7JU5 1 HETSYN REVDAT 3 27-JAN-21 7JU5 1 JRNL REVDAT 2 25-NOV-20 7JU5 1 JRNL REVDAT 1 11-NOV-20 7JU5 0 JRNL AUTH V.SUBBIAH,T.SHEN,S.S.TERZYAN,X.LIU,X.HU,K.P.PATEL,M.HU, JRNL AUTH 2 M.CABANILLAS,A.BEHRANG,F.MERIC-BERNSTAM,P.T.T.VO, JRNL AUTH 3 B.H.M.MOOERS,J.WU JRNL TITL STRUCTURAL BASIS OF ACQUIRED RESISTANCE TO SELPERCATINIB AND JRNL TITL 2 PRALSETINIB MEDIATED BY NON-GATEKEEPER RET MUTATIONS. JRNL REF ANN ONCOL V. 32 261 2021 JRNL REFN ISSN 1569-8041 JRNL PMID 33161056 JRNL DOI 10.1016/J.ANNONC.2020.10.599 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 44787 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2389 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3097 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.4420 REMARK 3 BIN FREE R VALUE SET COUNT : 161 REMARK 3 BIN FREE R VALUE : 0.4230 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4623 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 264 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.31000 REMARK 3 B22 (A**2) : -0.89000 REMARK 3 B33 (A**2) : -1.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.83000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.169 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.164 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.143 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.191 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4966 ; 0.017 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4835 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6715 ; 1.823 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11143 ; 0.909 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 609 ; 5.873 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 216 ;35.178 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 912 ;15.931 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 39 ;22.684 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 712 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5565 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1148 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JU5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : FLAT BENT COLIMATOR RH COVERED REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47291 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.53200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.8.0073 REMARK 200 STARTING MODEL: 6NEC REMARK 200 REMARK 200 REMARK: TRANSPARENT SMALL CRYSTALS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21-30% PEG3350 0.1M NA CITRATE PH 5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.16450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 824 REMARK 465 GLY A 825 REMARK 465 TYR A 826 REMARK 465 LEU A 827 REMARK 465 GLY A 828 REMARK 465 SER A 829 REMARK 465 GLY A 830 REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 ARG A 833 REMARK 465 ASN A 834 REMARK 465 SER A 835 REMARK 465 SER A 836 REMARK 465 SER A 837 REMARK 465 LEU A 838 REMARK 465 ASP A 839 REMARK 465 HIS A 840 REMARK 465 PRO A 841 REMARK 465 ASP A 842 REMARK 465 GLU A 901 REMARK 465 GLU A 902 REMARK 465 ASP A 903 REMARK 465 SER A 904 REMARK 465 TYR A 905 REMARK 465 VAL A 906 REMARK 465 LYS A 907 REMARK 465 ARG A 908 REMARK 465 GLY B 700 REMARK 465 PRO B 701 REMARK 465 LEU B 702 REMARK 465 SER B 703 REMARK 465 LEU B 704 REMARK 465 SER B 705 REMARK 465 VAL B 706 REMARK 465 ASP B 707 REMARK 465 ALA B 708 REMARK 465 PHE B 709 REMARK 465 SER B 829 REMARK 465 GLY B 830 REMARK 465 GLY B 831 REMARK 465 SER B 832 REMARK 465 ARG B 833 REMARK 465 ASN B 834 REMARK 465 SER B 835 REMARK 465 SER B 836 REMARK 465 SER B 837 REMARK 465 LEU B 838 REMARK 465 ASP B 839 REMARK 465 HIS B 840 REMARK 465 PRO B 841 REMARK 465 ARG B 1013 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 714 CG OD1 OD2 REMARK 470 GLU A 843 CG CD OE1 OE2 REMARK 470 GLU A 867 CG CD OE1 OE2 REMARK 470 TYR A 900 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 734 CD GLU B 734 OE2 0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 873 -28.95 77.23 REMARK 500 TYR A 952 63.32 36.59 REMARK 500 GLN B 796 -62.70 -136.42 REMARK 500 ASP B 797 44.26 -94.73 REMARK 500 ARG B 873 -28.21 72.95 REMARK 500 GLU B 884 138.65 -39.44 REMARK 500 GLU B 902 -14.27 103.44 REMARK 500 LYS B1011 46.88 -90.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q4J A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q4J B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMT B 1103 DBREF 7JU5 A 705 1013 UNP P07949 RET_HUMAN 705 1013 DBREF 7JU5 B 705 1013 UNP P07949 RET_HUMAN 705 1013 SEQADV 7JU5 GLY A 700 UNP P07949 EXPRESSION TAG SEQADV 7JU5 PRO A 701 UNP P07949 EXPRESSION TAG SEQADV 7JU5 LEU A 702 UNP P07949 EXPRESSION TAG SEQADV 7JU5 SER A 703 UNP P07949 EXPRESSION TAG SEQADV 7JU5 LEU A 704 UNP P07949 EXPRESSION TAG SEQADV 7JU5 GLY B 700 UNP P07949 EXPRESSION TAG SEQADV 7JU5 PRO B 701 UNP P07949 EXPRESSION TAG SEQADV 7JU5 LEU B 702 UNP P07949 EXPRESSION TAG SEQADV 7JU5 SER B 703 UNP P07949 EXPRESSION TAG SEQADV 7JU5 LEU B 704 UNP P07949 EXPRESSION TAG SEQRES 1 A 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 A 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 A 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 A 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 A 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 A 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 A 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 A 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 A 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 A 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 A 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 A 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 A 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 A 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 A 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 A 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 A 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 A 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 A 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 A 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 A 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 A 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 A 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 A 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 A 314 ARG ARG SEQRES 1 B 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 B 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 B 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 B 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 B 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 B 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 B 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 B 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 B 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 B 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 B 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 B 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 B 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 B 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 B 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 B 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 B 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 B 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 B 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 B 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 B 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 B 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 B 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 B 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 B 314 ARG ARG HET Q4J A1101 39 HET FMT A1102 3 HET FMT A1103 3 HET Q4J B1101 39 HET FMT B1102 3 HET FMT B1103 3 HETNAM Q4J PRALSETINIB HETNAM FMT FORMIC ACID HETSYN Q4J BLU-667; TRANS-N-{(1S)-1-[6-(4-FLUORO-1H-PYRAZOL-1-YL) HETSYN 2 Q4J PYRIDIN-3-YL]ETHYL}-1-METHOXY-4-{4-METHYL-6-[(5- HETSYN 3 Q4J METHYL-1H-PYRAZOL-3-YL)AMINO]PYRIMIDIN-2- HETSYN 4 Q4J YL}CYCLOHEXANE-1-CARBOXAMIDE FORMUL 3 Q4J 2(C27 H32 F N9 O2) FORMUL 4 FMT 4(C H2 O2) FORMUL 9 HOH *264(H2 O) HELIX 1 AA1 GLY A 700 ILE A 711 1 12 HELIX 2 AA2 ASP A 714 GLU A 718 5 5 HELIX 3 AA3 PRO A 720 LYS A 722 5 3 HELIX 4 AA4 LEU A 746 ARG A 749 5 4 HELIX 5 AA5 SER A 765 LYS A 780 1 16 HELIX 6 AA6 SER A 811 GLU A 818 1 8 HELIX 7 AA7 THR A 847 MET A 868 1 22 HELIX 8 AA8 ALA A 876 ARG A 878 5 3 HELIX 9 AA9 ASP A 892 SER A 896 5 5 HELIX 10 AB1 PRO A 914 MET A 918 5 5 HELIX 11 AB2 ALA A 919 HIS A 926 1 8 HELIX 12 AB3 THR A 929 THR A 946 1 18 HELIX 13 AB4 PRO A 956 THR A 966 1 11 HELIX 14 AB5 SER A 977 TRP A 988 1 12 HELIX 15 AB6 GLU A 991 ARG A 995 5 5 HELIX 16 AB7 VAL A 997 LYS A 1011 1 15 HELIX 17 AB8 PRO B 720 LYS B 722 5 3 HELIX 18 AB9 LEU B 746 ARG B 749 5 4 HELIX 19 AC1 SER B 765 VAL B 782 1 18 HELIX 20 AC2 LEU B 812 SER B 819 1 8 HELIX 21 AC3 THR B 847 MET B 868 1 22 HELIX 22 AC4 ALA B 876 ARG B 878 5 3 HELIX 23 AC5 PRO B 914 MET B 918 5 5 HELIX 24 AC6 ALA B 919 HIS B 926 1 8 HELIX 25 AC7 THR B 929 THR B 946 1 18 HELIX 26 AC8 PRO B 956 GLU B 958 5 3 HELIX 27 AC9 ARG B 959 THR B 966 1 8 HELIX 28 AD1 SER B 977 TRP B 988 1 12 HELIX 29 AD2 GLU B 991 ARG B 995 5 5 HELIX 30 AD3 VAL B 997 LYS B 1011 1 15 SHEET 1 AA1 5 LEU A 724 GLU A 732 0 SHEET 2 AA1 5 GLY A 736 PHE A 744 -1 O LYS A 740 N GLY A 727 SHEET 3 AA1 5 TYR A 752 LEU A 760 -1 O VAL A 755 N ALA A 741 SHEET 4 AA1 5 LEU A 801 GLU A 805 -1 O VAL A 804 N ALA A 756 SHEET 5 AA1 5 LEU A 790 CYS A 794 -1 N GLY A 792 O ILE A 803 SHEET 1 AA2 2 ARG A 820 LYS A 821 0 SHEET 2 AA2 2 ALA A 845 LEU A 846 1 O LEU A 846 N ARG A 820 SHEET 1 AA3 2 LEU A 870 VAL A 871 0 SHEET 2 AA3 2 ARG A 897 ASP A 898 -1 O ARG A 897 N VAL A 871 SHEET 1 AA4 2 ILE A 880 ALA A 883 0 SHEET 2 AA4 2 LYS A 887 ILE A 890 -1 O LYS A 889 N LEU A 881 SHEET 1 AA5 5 LEU B 724 GLU B 732 0 SHEET 2 AA5 5 GLY B 736 PHE B 744 -1 O THR B 742 N VAL B 725 SHEET 3 AA5 5 TYR B 752 LEU B 760 -1 O VAL B 757 N VAL B 739 SHEET 4 AA5 5 LEU B 801 GLU B 805 -1 O LEU B 802 N LYS B 758 SHEET 5 AA5 5 LEU B 790 CYS B 794 -1 N TYR B 791 O ILE B 803 SHEET 1 AA6 3 GLY B 810 SER B 811 0 SHEET 2 AA6 3 ILE B 880 ALA B 883 -1 O VAL B 882 N GLY B 810 SHEET 3 AA6 3 LYS B 887 ILE B 890 -1 O LYS B 889 N LEU B 881 SHEET 1 AA7 2 GLY B 825 TYR B 826 0 SHEET 2 AA7 2 ALA B 845 LEU B 846 1 O LEU B 846 N GLY B 825 SHEET 1 AA8 2 LEU B 870 VAL B 871 0 SHEET 2 AA8 2 ARG B 897 ASP B 898 -1 O ARG B 897 N VAL B 871 SHEET 1 AA9 2 TYR B 905 VAL B 906 0 SHEET 2 AA9 2 ILE B 927 TYR B 928 -1 O TYR B 928 N TYR B 905 CISPEP 1 GLY B 823 PRO B 824 0 0.36 SITE 1 AC1 19 LEU A 730 GLY A 731 GLU A 732 GLY A 733 SITE 2 AC1 19 GLY A 736 LYS A 737 VAL A 738 ALA A 756 SITE 3 AC1 19 LYS A 758 MET A 759 LEU A 772 GLU A 805 SITE 4 AC1 19 TYR A 806 ALA A 807 GLY A 810 LEU A 881 SITE 5 AC1 19 HOH A1237 HOH A1239 HOH A1251 SITE 1 AC2 6 GLN A 910 GLY A 911 HIS A 926 TYR A 928 SITE 2 AC2 6 HOH A1231 HOH A1265 SITE 1 AC3 7 GLY A 700 PRO A 701 LEU A 702 SER A 703 SITE 2 AC3 7 GLN B 910 LEU B 923 HIS B 926 SITE 1 AC4 17 LEU B 730 GLY B 731 GLY B 733 GLY B 736 SITE 2 AC4 17 LYS B 737 ALA B 756 MET B 759 LEU B 772 SITE 3 AC4 17 GLU B 805 TYR B 806 ALA B 807 GLY B 810 SITE 4 AC4 17 ARG B 878 LEU B 881 FMT B1103 HOH B1206 SITE 5 AC4 17 HOH B1233 SITE 1 AC5 6 SER B 909 GLY B 911 SER B 922 HIS B 926 SITE 2 AC5 6 TYR B 928 HOH B1282 SITE 1 AC6 4 LYS B 728 LYS B 740 TYR B 806 Q4J B1101 CRYST1 50.449 80.329 79.840 90.00 100.25 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019822 0.000000 0.003583 0.00000 SCALE2 0.000000 0.012449 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012728 0.00000